TP53 and prostate carcinoma: Why does CCDC3 act as a tumor suppressor in some cancers, such as wild-type p53-containing BrC and prostate cancer, but potentially as an oncoprotein in other cancers, such as cervical carcinoma and mutant p53-containing BrC?